Innate Pharma S.A.

IPHYF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$66,396$70,605$84,225$103,756
Short-Term Investments$14,374$21,851$17,260$16,080
Receivables$1,643$46,489$3,080$846
Inventory$0$0-$2$0
Other Curr. Assets$3,329$9,067$35,268$17,574
Total Curr. Assets$85,742$148,012$139,831$138,256
Property Plant & Equip (Net)$5,133$6,322$8,542$10,174
Goodwill$0$0-$40,997$2
Intangibles$0$416$42,553$44,190
Long-Term Investments$10,281$9,796$35,119$39,878
Tax Assets$0$9,006$8,568$5,028
Other NC Assets$9,903$1,635$14,248$29,969
Total NC Assets$25,317$27,175$68,033$129,241
Other Assets$0$0-$1-$1
Total Assets$111,059$175,187$207,863$267,496
Liabilities
Payables$7,923$8,561$13,656$14,729
Short-Term Debt$8,709$8,936$2,102$30,748
Tax Payable$6,962$7,021$5,978$7,463
Deferred Revenue$616$5,865$6,560$12,500
Other Curr. Liab.$8,772$9,254$13,042$14,446
Total Curr. Liab.$32,982$39,637$41,338$79,886
LT Debt$22,286$30,957$40,149$13,503
Deferred Rev, NC$2,825$4,618$7,921$25,413
Deferred Tax Liab, NC$0$9,006$8,568$5,028
Other NC Liab.$44,132$39,069$55,736$36,226
Total NC Liab.$69,243$83,650$112,374$80,170
Other Liabilities$0$0$0$0
Cap. Leases$375$835$2,044$2,816
Total Liabilities$102,225$132,292$153,712$160,056
Equity
Pref Stock$0$0$0$0
Common Stock$4,192$4,044$4,011$3,978
Retained Earnings-$386,364-$336,893-$330,316-$272,213
AOCI$27$495$819$456
Other Equity$390,979$384,255$379,637$375,219
Total Equity$8,834$51,901$54,151$107,440
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$111,059$184,193$207,863$267,496
Net Debt-$35,401-$30,712-$41,974-$59,505
Innate Pharma S.A. (IPHYF) Financial Statements & Key Stats | AlphaPilot